Solvias Achieves Strong First Sustainability Assessment from EcoVadis

Solvias Earns Strong First Sustainability Assessment from EcoVadis

Solvias, a global leader in chemistry, manufacturing, and control (CMC) analysis, has recently been honored with a 'Committed' badge from EcoVadis after completing its first sustainability assessment through the world-renowned provider of corporate sustainability ratings. This distinction places Solvias among the top-tier organizations, demonstrating its commitment to incorporating Environmental, Social, and Governance (ESG) principles into its core business practices.

Since the launch of its ESG initiative in 2024, Solvias has made significant strides in establishing a solid framework for sustainability. The company has calculated its carbon footprint, set clear sustainability goals, and developed a comprehensive five-year action plan aimed at reducing its environmental impact and driving meaningful change.

The positive rating from EcoVadis serves as a robust foundation for Solvias to accelerate its sustainability efforts. In alignment with this commitment, the company plans to formally join the Science Based Targets initiative (SBTi) in the coming months. The SBTi is a global organization that aids companies in reducing their greenhouse gas emissions, thereby consolidating Solvias' long-term strategy for promoting sustainability.

Archie Cullen, CEO of Solvias, stated, "Our first EcoVadis assessment is a pivotal milestone that confirms our progress and heightens our focus on driving effective change. We take pride in what we have achieved and remain dedicated to effectively integrating sustainability into our business."

With a well-established five-year plan, Solvias is actively undertaking initiatives to meet its sustainability objectives. These efforts aim for continuous improvement, higher ratings, and measurable contributions toward a more sustainable future.

About Solvias

Solvias is a global provider of chemistry, manufacturing, and control (CMC) analyses for the life sciences industry. Its team of experts boasts decades of experience with regulatory requirements for small molecules, biologics, cellular therapies, and gene therapies. Solvias delivers end-to-end solutions from the testing of raw materials to the release of pharmaceuticals and the development of active pharmaceutical ingredients (APIs) for small molecules. Headquartered near Basel, Switzerland, Solvias operates six global competence centers, all meeting the highest standards of ISO, GMP, GLP, and FDA. For more information, please visit solvias.com.